MTHFR C677T Polymorphism and Factor V Leiden Mutation Are Not Associated with Recurrent Spontaneous Abortion of Unexplained Etiology in Japanese Women

ABSTRACT

To determine whether the C677T polymorphism of the methylenetetrahydrofolate reductase (MTHFR) gene and the Leiden mutation of coagulation factor V (FV) are associated with recurrent spontaneous abortion (RSA) of unexplained etiology in Japanese participants, the genotypes of the two polymorphisms were determined and compared between cases of unexplained RSA and normal pregnant controls. Eighty-three Japanese participants, consisting of 45 women with explained RSA and 38 women with unexplained RSA, and 174 controls were recruited in the study. The frequencies of the T677 allele/TT genotype were not significantly different among women with explained RSA (35.6%/13.3%), women with unexplained RSA (34.2%/7.9%), primigravid controls (35.1%/11.7%), and multigravid controls (39.7%/16.5%). In the cases of unexplained RSA, the frequencies of the T677 allele and TT genotype tended to increase according to the number of previous spontaneous abortions, but the increase was without statistical significance: the frequencies of the T677 allele and TT genotype in women with two abortions were 18.2% and 0%, whereas in women with three abortions the frequencies were 38.0% and 9.5%, and in women with four or more abortions the frequencies were 50.0% and 16.7%, respectively. In addition, no Leiden mutation of FV was detected in the women with RSA or the controls. Neither T677 of the MTHFR nor the Leiden mutation of FV was associated with unexplained RSA in the Japanese population.

KEYWORDS

Recurrent spontaneous abortion - MTHFR - factor V - gene - polymorphism

REFERENCES

• 1 Blumenfeld Z, Brenner B. Thrombophilia-associated pregnancy wastage.  Fertil Steril. 1999;  72 765-774
• 2 Katz V, Kuller J. Recurrent miscarriage.  Am J Perinatol. 1994;  11 386-397
• 3 Preston F E, Rosendaal F R, Walker I D et al.. Increased fetal loss in women with heritable thrombophilia.  Lancet. 1996;  348 913-916
• 4 Arruda V R. Von zuben PM, Ciapurini LC, Annichino-Bizzachi JM, Costa FF. The mutation Ala677-Val in the methylenetetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis.  Thromb Haemost. 1997;  77 818-821
• 5 Bertina R M, Koclaman B P, Koster T et al.. Mutation in the blood coagulation factor V associated with resistance to activated protein C.  Nature. 1994;  369 64-67
• 6 Frosst P, Blom H J, Milos R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase.  Nat Genet. 1995;  10 111-113
• 7 Kang S S, Zhou J, Wong P W, Kowalisyn J, Strokosch G. Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase.  Am J Hum Genet. 1988;  43 414-421
• 8 Goyette P, Sumner J S, Milos R et al.. Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification.  Nat Genet. 1994;  7 195-200
• 9 Jacques P F, Bostom A G, Williams R R et al.. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations.  Circulation. 1996;  93 7-9
• 10 Kluijtmans L A, van den Heuvel L P, Boers G H et al.. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease.  Am J Hum Genet. 1996;  58 35-41
• 11 Rees M M, Rodgers G M. Homocysteinemia: association of a metabolic disorder with vascular disease and thrombosis.  Thromb Res. 1993;  71 337-359
• 12 Berry R J, Li Z, Erickson J D et al.. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention.  N Engl J Med. 1999;  341 1485-1490
• 13 Steegers-Theunissen R P, Boers G H, Blom H J, Trijbels F J, Eskes T K. Hyperhomocysteinaemia and recurrent spontaneous abortion or abruptio placentae.  Lancet. 1992;  339 1122-1123
• 14 Rajkovic A, Catalano P M, Malinow M R. Elevated homocyst(e)ine levels with preeclampsia.  Obstet Gynecol. 1997;  90 168-171
• 15 Kobashi G, Yamada H, Asano T et al.. Absence of association between a common mutation in the methylenetetrahydrofolate reductase gene and preeclampsia in Japanese.  Am J Med Genet. 2000;  93 122-125
• 16 Nelen W L, Steegers E A, Eskes T K, Blom H J. Genetic risk factor for unexplained recurrent early pregnancy loss.  Lancet. 1997;  350 861
• 17 Quere I, Bellet H, Hoffet M, Janbon C, Mares P, Gris J C. A woman with five consecutive fetal deaths: case report and retrospective analysis of hyperhomocysteinemia prevalence in 100 consecutive women with recurrent miscarriages.  Fertil Steril. 1998;  69 152-154
• 18 Holmes Z R, Regan L, Chilcott I, Cohen H. The C677T MTHFR gene mutation is not predictive of risk for recurrent fetal loss.  Br J Haematol. 1999;  105 98-101
• 19 Wramsby M L, Stein-Linder , Bremme K. Primary habitual abortions are associated with high frequency of factor F Leiden mutation.  Fertil Steril. 2000;  74 987-991
• 20 Fokka Z J, Lambropoulos A F, Saravelos H et al.. Factor V Leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages.  Hum Reprod. 2000;  15 458-462
• 21 Dilley A, Benito C, Hooper W C et al.. Mutations in the factor V, prothrombin and MTHFR genes are not risk factors for recurrent fetal loss.  J Matern Fetal Neonatal Med. 2002;  11 176-182
• 22 Carp H, Salomon O, Seidman D, Dardik R, Rosenberg N, Inbal A. Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss.  Hum Reprod. 2002;  17 1633-1637
• 23 Tamakoshi A, Ishikawa S, Ojima T et al.. The Guideline of Informed Consent in Epidemiological Studies. Ver. 1.0 Tokyo; Nihonijishinposya 2000: 1-27
• 24 Kobashi G, Yamada H, Asano T et al.. The factor V Leiden mutation is not a common cause of pregnancy-induced hypertension in Japan.  Semin Thromb Hemost. 1999;  25 487-489
• 25 Parazzini F, Bocciolone L, Fedele L, Negri E, La Vecchia C, Acaia B. Risk factors for spontaneous abortion.  Int J Epidemiol. 1991;  20 157-161
• 26 Cramer D W, Wise L A. The epidemiology of recurrent pregnancy loss.  Semin Reprod Med. 2000;  18 331-339
• 27 Fenster L, Eskenazi B. Windham G C, Swan S H. Caffeine consumption during pregnancy and spontaneous abortion.  Epidemiology. 1991;  2 168-174
• 28 Sata F, Yamada H, Kondo T, Fujimoto S, Kishi R. Glutathione S-transferase M1 and T1 polymorphisms and the risk of recurrent pregnancy loss.  Mol Hum Reprod. 2003;  9 165-169
• 29 Zusterzeel P L, Nelen W L, Roelofs H M, Peters W H, Blom H J, Steegers E A. Polymorphisms in biotransformation enzymes and the risk for recurrent early pregnancy loss.  Mol Hum Reprod. 2000;  6 474-478
• 30 Reid J G, Simpson N A, Walker R G et al.. The carriage of pro-inflammatory cytokine gene polymorphisms in recurrent pregnancy loss.  Am J Reprod Immunol. 2001;  45 35-40
• 31 Unfried G, Tempfer C, Schneeberger C, Widmar B, Nagele F, Huber J C. Interleukin 1 receptor antagonist polymorphism in women with idiopathic recurrent miscarriage.  Fertil Steril. 2001;  75 683-687
• 32 Wang Z C, Yunis E J, De los Santos M J, Xiao L, Anderson D J, Hill J A. T helper 1-type immunity to trophoblast antigens in women with a history of recurrent pregnancy loss is associated with polymorphism of the IL1B promoter region.  Genes Immun. 2002;  3 38-42
• 33 Unfried G, Bocskor S, Endler G, Nagele F, Huber J C, Tempfer C B. A polymorphism of the interleukin-6 gene promoter and idiopathic recurrent miscarriage.  Hum Reprod. 2003;  18 267-270
• 34 Wramsby M L, Sten-Linder M, Bremme K. Primary habitual abortions are associated with high frequency of factor V Leiden mutation.  Fertil Steril. 2000;  74 987-991
• 35 Pihusch R, Buchholz T, Lohse P et al.. Thrombophilic gene mutations and recurrent spontaneous abortion: prothrombin mutation increases the risk in the first trimester.  Am J Reprod Immunol. 2001;  46 124-131
• 36 Aldrich C L, Stephenson M D, Karrison T et al.. HLA-G genotypes and pregnancy outcome in couples with unexplained recurrent miscarriage.  Mol Hum Reprod. 2001;  7 1167-1172
• 37 Lissak A, Sharon A, Fruchter O, Kassel A, Sanderovitz J, Abramovici H. Polymorphism for mutation of cytosine to thymine at location 677 in the methylenetetrahydrofolate reductase gene is associated with recurrent early fetal loss.  Am J Obstet Gynecol. 1999;  181 126-130
• 38 Rey E, Kahn S R, David M, Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis.  Lancet. 2003;  361 901-908
• 39 Morita H, Kurihara H, Tsubaki S et al.. Methylenetetrahydrofolate reductase gene polymorphism and ischemic stroke in Japanese.  Arterioscler Thromb Vasc Biol. 1998;  18 1465-1469
• 40 Kowa H, Yasui K, Takeshima T, Urakami K, Sakai F, Nakashima K. The homozygous C677T mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for migraine.  Am J Med Genet. 2000;  96 762-764
• 41 Goodman M T, McDuffie K, Hernandez B et al.. Association of methylenetetrahydrofolate reductase polymorphism C677T and dietary folate with the risk of cervical dysplasia.  Cancer Epidemiol Biomarkers Prev. 2001;  10 1275-1280
• 42 McCully K S. Homocysteine and vascular disease.  Nat Med. 1996;  2 386-389
• 43 Ray J G, Laskin C A. Folic acid and homocyst(e)ine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: a systematic review.  Placenta. 1999;  20 519-529
• 44 Morita H, Taguchi J, Kurihara H et al.. Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease.  Circulation. 1997;  95 2032-2036
• 45 Kodaira H, Ishida F, Shimodaira S, Takamiya O, Furihata K, Kitano K. Resistance to activated protein C and Arg 503 Gln factor V mutation are uncommon in eastern Asian populations.  Acta Haematologica. 1997;  98 22-25
• 46 Ohnishi Y, Tanaka T, Yamada R et al.. Identification of 187 single nucleotide polymorphisms (SNPs) among 41 candidate genes for ischemic heart disease in the Japanese population.  Hum Genet. 2000;  106 288-292